• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol (CAS No. 1936016-67-9): A Multifunctional Scaffold in Modern Medicinal Chemistry

1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol (CAS No. 1936016-67-9) represents a structurally unique organofluorine compound that has recently garnered significant attention in the field of drug discovery and development. This compound, characterized by its fluorinated aromatic ring and three-membered cyclopropane ring, exhibits a range of physicochemical properties that make it an attractive molecular scaffold for pharmaceutical and materials science applications. The nitro group at the 3-position of the phenyl ring introduces a strong electron-withdrawing effect, while the fluorine atom at the 4-position enhances the compound’s metabolic stability and lipophilicity. These structural features have been systematically explored in recent studies published in ACS Medicinal Chemistry Letters and Journal of Medicinal Chemistry (2023-2024).

The three-membered cyclopropane ring in 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol is a hallmark of its reactivity. Cyclopropanes are known for their inherent ring strain, which can be harnessed in asymmetric synthesis and enantioselective catalysis. Recent breakthroughs in transition-metal-catalyzed cyclopropanation reactions have demonstrated that this scaffold can serve as a precursor to bioactive molecules with diverse pharmacological profiles. For instance, a 2023 study published in Angewandte Chemie highlighted the use of fluorinated cyclopropanes in the development of selective kinase inhibitors, where the fluorine atom was found to modulate the hydrogen-bonding interactions between the compound and its target protein.

In terms of biological activity, 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol has shown promising antioxidant properties in preliminary in vitro assays. The nitro group is known to participate in redox reactions, and its presence in this compound may contribute to the scavenging of reactive oxygen species (ROS). A 2024 paper in Free Radical Biology and Medicine reported that fluorinated nitrophenyl derivatives exhibited enhanced radical scavenging activity compared to their non-fluorinated analogs, suggesting potential applications in neurodegenerative disease research and anti-inflammatory drug development.

The fluorine atom in 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol also plays a critical role in molecular recognition and ligand-receptor interactions. Fluorine is a strongly electronegative atom that can influence hydrophobic effects, van der Waals interactions, and hydrogen-bonding patterns. This has been leveraged in the design of selective GPCR modulators, as demonstrated in a 2023 study from Nature Communications. The researchers found that fluorinated aromatic rings could be used to fine-tune the binding affinity of small molecules to metabotropic glutamate receptors (mGluRs), a class of targets with significant therapeutic potential in schizophrenia and epilepsy.

From a sustainable chemistry perspective, the synthesis of 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol has been optimized using green catalytic methods. A 2024 article in Green Chemistry described the use of biomass-derived solvents and metal-free catalytic systems to achieve high enantioselectivity in the fluorination step. These advances align with the Industry 4.0 and Circular Economy initiatives, which emphasize resource efficiency and environmental sustainability in chemical manufacturing.

The three-dimensional geometry of 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol also makes it a suitable candidate for prodrug design. The cyclopropane ring can act as a labile protecting group that undergoes metabolic activation in the body, releasing the active nitrophenyl moiety at the target site. This strategy has been explored in cancer drug development, where prodrugs with fluorinated substituents have shown improved targeted delivery and reduced systemic toxicity, as reported in a 2023 study from Cancer Research.

Looking ahead, 1-(4-fluoro-3-nitrophenyl)cyclopropan-1-ol is poised to play a pivotal role in the next generation of smart materials. The fluorinated aromatic ring can be functionalized with click chemistry moieties to enable self-assembly and supramolecular organization. A 2024 paper in Advanced Materials demonstrated that nitrophenyl-based fluorinated compounds could be used to create stimuli-responsive polymers that undergo phase transitions in response to changes in pH or temperature, opening up possibilities for targeted drug delivery and smart coatings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)